Scioto Biosciences, Inc.

As the global pharma industry steps closer to witnessing the first approval of a microbiome therapeutic, some players in the sector are already making moves to diversify into manufacturing to get ahea

Cell and gene therapy companies raised $10.7bn during the first half of 2020, exceeding the $9.8bn full-year total that the regenerative medicine sector raised in 2019. Venture capital financings in t